(SAVA) – Corporate News
-
Cassava Sciences (SAVA) Sets May 6th as Final Day to Exercise Warrants
-
Cassava Sciences (SAVA) Announces Completion of an Interim Safety Review of Oral Simufilam On-going Phase 3 Trials
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to SAVA Stock Lookup